申请人:Pfizer Inc.
公开号:US06506779B1
公开(公告)日:2003-01-14
The present invention relates to compounds of the formula
wherein R1, R2, R3, R4, R5, R6, X and Y are defined as in the specification, to pharmaceutical compositions containing them and to their medicinal use. The compounds of the invention are useful in the treatment or alleviation of inflammation and other inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock.
本发明涉及以下式的化合物
其中R1、R2、R3、R4、R5、R6、X和Y的定义如规范中所述,以及含有它们的药物组合物及其药用。本发明的化合物在治疗或缓解炎症及其他与炎症相关的疾病方面具有用途,如关节炎、结肠癌和阿尔茨海默病等哺乳动物,最好是人类、狗、猫和家畜。